DNA And Gene Cloning Services Market To Reach USD 15.60 Billion by 2034 at 15.7% CAGR | DelveInsight

DelveInsight's "DNA and Gene Cloning Services Market Insights, Size, and Forecast 2034" report delivers an in-depth understanding of the DNA and gene cloning services market trends, growth drivers, restraints, competitive landscape, and regional dynamics across North America, Europe, Asia-Pacific, and the Rest of the World.

Explore the intricate details of the DNA and Gene Cloning Services Market Report @ https://www.delveinsight.com/report-store/dna-and-gene-cloning-services-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

Key Takeaways from DNA and Gene Cloning Services Market Report
• In January 2025, Azenta, Inc., through GENEWIZ, launched a high-efficiency site-directed mutagenesis service designed for oncology and virology research, enabling faster generation of variant libraries. The initiative strengthened advanced mutagenesis capabilities and expanded variant library solutions to support therapeutic discovery and research applications.
• In February 2025, Thermo Fisher Scientific Inc. enhanced its gene synthesis and cloning portfolio by introducing support for good manufacturing practice (GMP)-grade plasmid production for cell and gene therapy developers. The expansion reinforced GMP-compliant cloning capabilities and accelerated the availability of clinical-grade plasmid manufacturing services.
• In May 2025, Twist Bioscience Corporation updated its collaboration with a synthetic biology partner by securing long DNA technology licenses and strengthening its DNA synthesis capabilities. The advancement improved long DNA synthesis expertise and supported the continued expansion of its DNA synthesis and cloning portfolio.
• The global DNA and gene cloning services market was valued at USD 4.20 billion in 2025 and is projected to reach USD 15.60 billion by 2034, growing at a CAGR of 15.7% during the forecast period 2026-2034.
• By service type, the gene synthesis segment dominated the market with a 38% share in 2025.
• By application, the drug discovery and development segment dominated the market with a 36% share in 2025.
• By end-user, the pharmaceutical and biotechnology companies segment dominated the market with a 44% share in 2025.
• By grade, the research-use segment dominated the market with a 68% share in 2025.
• North America accounted for the largest share of the market at 41% in 2025, while Asia-Pacific is anticipated to register the fastest growth through 2034.
• The DNA and Gene Cloning Services Companies include GenScript Biotech Corporation, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, Integrated DNA Technologies, Inc., Azenta, Inc., ATUM, Eurofins Scientific SE, Takara Bio Inc., Merck KGaA, Macrogen, Inc., and others.

Get a Free sample for the DNA and Gene Cloning Services Market Forecast, Size & Share Analysis Report @ https://www.delveinsight.com/sample-request/dna-and-gene-cloning-services-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

What is DNA and Gene Cloning Services?
DNA and gene cloning services are outsourced molecular biology services that design, synthesize, clone, and construct genes, vectors, and DNA constructs for research, therapeutic, and industrial applications. The scope encompasses gene synthesis, in which custom DNA sequences are synthesized de novo; molecular cloning and subcloning, in which genes are inserted into vectors; vector construction and mutagenesis; plasmid preparation, codon optimization, and library construction. These services free researchers from the labor of molecular biology and provide the building blocks of recombinant protein production, genome editing, vaccine development, and cell and gene therapy.

DNA and Gene Cloning Services Market Segmentation
• Service Type: Gene Synthesis, Molecular Cloning and Subcloning, Vector Construction and Mutagenesis, Plasmid Preparation and Others
• Application: Drug Discovery and Development, Synthetic Biology, Academic and Basic Research, Others
• End-User: Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research and Manufacturing Organizations, Others
• Grade: Research-Use, Good Manufacturing Practice and Clinical-Grade
• Geography: North America, Europe, Asia-Pacific, Rest of the World

Download the report to understand which factors are driving DNA and gene cloning services market trends @ https://www.delveinsight.com/report-store/dna-and-gene-cloning-services-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

DNA and Gene Cloning Services Market Key Growth Drivers
• Growth of biologics and gene-based therapeutics, including monoclonal antibodies, messenger RNA vaccines, and gene therapies that begin with the cloning and expression of target sequences.
• Expansion of synthetic biology and cell and gene therapy, which depend on gene synthesis, cloning, and vector construction.
• Advances in gene synthesis and cloning technology, including silicon-chip synthesis, error correction, and automation that increase throughput and reduce cost.
• Outsourcing of molecular biology to specialized service providers with the expertise, capacity, and turnaround that researchers require.
• Growth of good manufacturing practice cloning and plasmid production for the clinical development of cell and gene therapy and vaccines.
• Growth of research funding and the demand for gene synthesis and cloning across academic and industrial research.
• Adoption of artificial intelligence and automated design platforms that optimize sequence design and cloning success.

DNA and Gene Cloning Services Market Restraints
The market faces restraints including the complexity and cost of high-value and clinical-grade services, biosecurity screening and export control obligations under the harmonized screening protocol of the International Gene Synthesis Consortium, technical challenges in synthesizing difficult sequences, price pressure from the commoditization of standard gene synthesis and cloning, a shortage of skilled molecular biology professionals, variability of turnaround and quality across providers, and intellectual property and licensing complexities tied to cloning technologies and vectors.

DNA and Gene Cloning Services Companies
GenScript Biotech Corporation, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, Integrated DNA Technologies, Inc., Azenta, Inc., ATUM, Eurofins Scientific SE, Takara Bio Inc., Merck KGaA, Macrogen, Inc., and others.

Discover more about companies set to grab major DNA and Gene Cloning Services market share @ https://www.delveinsight.com/sample-request/dna-and-gene-cloning-services-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

DNA and Gene Cloning Services Market Outlook
North America led the market with a 41% share in 2025, supported by an advanced biotechnology and pharmaceutical industry, a concentration of gene synthesis and cloning providers, strong research funding, and growth in cell and gene therapy, with the United States as the largest national market. Asia-Pacific is projected to be the fastest-growing region through 2034, driven by rapid biotechnology and pharmaceutical industry growth, expanding research and manufacturing capacity, and increasing research funding across China, India, Japan, and South Korea. Europe remains a substantial market shaped by providers such as Eurofins and Merck, while the Rest of World represents an emerging opportunity as biotechnology research and healthcare investment grow. The market is classified as fragmented, with competition centered on synthesis throughput and cost, construct accuracy, breadth of services from synthesis to good manufacturing practice production, turnaround, and biosecurity compliance.

Scope of the DNA and Gene Cloning Services Market Report
• Study Period: 2023-2034
• Forecast Period: 2026-2034
• Coverage: North America, Europe, Asia-Pacific, Rest of the World
• DNA and Gene Cloning Services Companies: GenScript Biotech Corporation, Thermo Fisher Scientific Inc., Twist Bioscience Corporation, Integrated DNA Technologies, Inc., Azenta, Inc., and others
• DNA and Gene Cloning Services Market Segmentation: By Service Type, Application, End-User, Grade, and Geography
• DNA and Gene Cloning Services Market Dynamics: Market drivers and market restraints
• Competitive Landscape Analysis: Market concentration, leading players, geographic reach, product portfolio strength, pipeline strength, strategic partnerships, M&A activity, innovation focus, and regulatory standing

To know more about DNA and gene cloning services companies working in the market, visit @ https://www.delveinsight.com/sample-request/dna-and-gene-cloning-services-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=akpr

Table of Contents
• DNA and Gene Cloning Services Market Introduction
• DNA and Gene Cloning Services Market Executive Summary
• DNA and Gene Cloning Services Market Key Factors Analysis
• Impact Analysis: AI, Geopolitical, Trade, and Economic Developments
• Regulatory and Biosecurity Analysis
• DNA and Gene Cloning Services Market Porter's Five Forces Analysis
• DNA and Gene Cloning Services Market Assessment
• DNA and Gene Cloning Services Market Competitive Landscape
• DNA and Gene Cloning Services Market Startup Funding and Investment Trends
• DNA and Gene Cloning Services Market Company and Service Profiles
• DNA and Gene Cloning Services Report KOL Views
• Project Approach
• About DelveInsight
• Disclaimer and Contact Us

Company Name: DelveInsight Business Research LLP
Contact Person: Abhishek kumar
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com

About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

This release was published on openPR.